<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04279158</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL19_0728</org_study_id>
    <secondary_id>2019-A03055-52</secondary_id>
    <nct_id>NCT04279158</nct_id>
  </id_info>
  <brief_title>Attention Modulation of Local and Global Inhibition Mechanisms</brief_title>
  <acronym>MILGattention</acronym>
  <official_title>Attention Modulation of Local and Global Inhibition Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human behavior is both flexible and adapted to the environmental context through inhibition&#xD;
      capabilities; the investigator control the subject's behavior by repressing inappropriate&#xD;
      responses and selecting, among several possibilities, those that are appropriate. These&#xD;
      mechanisms are not independent of attentional control. Attention acts as a selection filter&#xD;
      for the investigator's behavior. This leads us to hypothesize that attention modulates the&#xD;
      mechanisms of inhibition. Nevertheless, the different brain structures involved, as well as&#xD;
      mechanisms underlying the interaction between inhibition and attention remain largely&#xD;
      unknown.&#xD;
&#xD;
      Previous research has suggested that inhibition requires selective attention and, conversely,&#xD;
      attentional mechanisms would result in the &quot;deselection&quot;, or inhibition, of objects in space&#xD;
      or irrelevant actions. Reconciling the literature on attention with the one on inhibition&#xD;
      appears fundamental for the understanding of the instance to which the mechanisms of&#xD;
      inhibition and the cognitive processes interact. Therefore, the goal of this research project&#xD;
      will be to investigate how inhibition mechanisms are implemented in the brain and, in more&#xD;
      detail, what determines the type of resulting inhibitory control: spatially localized or&#xD;
      global. The investigator will test 3 different patient groups (optic ataxia, hemispatial&#xD;
      neglect and attention-deficit hyperactivity disorder) compared to control.&#xD;
&#xD;
      In conclusion, this research project will aim to develop a theoretical model of the&#xD;
      interaction between attentional control and inhibition mechanisms in order to improve&#xD;
      diagnostic and rehabilitation tools in the future.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2020</start_date>
  <completion_date type="Anticipated">September 2026</completion_date>
  <primary_completion_date type="Anticipated">September 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>error rate</measure>
    <time_frame>at the end of the simulation passage, an average of 3 years</time_frame>
    <description>The investigator calculate the number of right and wrong answers (a correct answer is a saccade carried out when it is necessary and by reaching the target; a false answer is a saccade made at the wrong time and / or not reaching the target) to obtain the error rate.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>reaction time</measure>
    <time_frame>at the end of the simulation passage, an average of 3 years</time_frame>
    <description>The investigator measure the time it takes for the subject to respond (perform the eye saccade)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Optical Phenomena</condition>
  <arm_group>
    <arm_group_label>patients with optic ataxia (OA)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with hemispatial neglect</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with attention-deficit hyperactivity disorder</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>experience 1 &quot;The negative priming task&quot;</intervention_name>
    <description>The targets are presented to the subject on a computer screen. The subject must make an eye or hand movement toward the target and ignore the distracters.</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>patients with attention-deficit hyperactivity disorder</arm_group_label>
    <arm_group_label>patients with hemispatial neglect</arm_group_label>
    <arm_group_label>patients with optic ataxia (OA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>experience 2 &quot;Stop signal task&quot;</intervention_name>
    <description>The targets are presented to the subject on a computer screen. The subject must make an eye movement towards this target. Sometimes a stop signal will appear and the subject will have to avoid to look at the target</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>patients with attention-deficit hyperactivity disorder</arm_group_label>
    <arm_group_label>patients with hemispatial neglect</arm_group_label>
    <arm_group_label>patients with optic ataxia (OA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>experience 3 &quot;Anti-saccades&quot;</intervention_name>
    <description>The targets are presented to the subject on a computer screen. The subject must make an eye movement toward this target. Sometimes an instruction will ask the subject to look at the opposite of the target</description>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>patients with attention-deficit hyperactivity disorder</arm_group_label>
    <arm_group_label>patients with hemispatial neglect</arm_group_label>
    <arm_group_label>patients with optic ataxia (OA)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        All patients and healthy subjects:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  male and female, age from 18 to 75 years included&#xD;
&#xD;
          -  normal vision or corrected vision&#xD;
&#xD;
          -  covered by social security&#xD;
&#xD;
          -  signed written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unable to comply with requirements of the study (neurological, psychiatric, sensory or&#xD;
             motor troubles)&#xD;
&#xD;
          -  adults under legal protection&#xD;
&#xD;
        Patient with hemispatial neglect:&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          -  After a stroke (&gt; 1 month ago), presence of a neurological impairment documented by&#xD;
             brain imaging (standard of care) and by clinical symptoms.&#xD;
&#xD;
          -  The diagnosis will be dissociated from hemianopia by perimetry. The hemispatial&#xD;
             neglect consists of a lack of perception and responsiveness concerning the&#xD;
             controlesional visual hemifield.&#xD;
&#xD;
        Patient with optic ataxia:&#xD;
&#xD;
          -  After a stroke (&gt; 1 month ago), presence of neurological injury in parietal cortex&#xD;
             only, supported by a standard of care cerebral MRI&#xD;
&#xD;
          -  Present optic ataxia symptoms (The OA consists of pointing errors with the hand&#xD;
             contralateral to the lesion (hand effect) and / or to visual targets presented in the&#xD;
             field contralateral to the lesion (field effect)).&#xD;
&#xD;
        Patient (adult and children) with attention-deficit hyperactivity disorder:&#xD;
&#xD;
          -  present a diagnosis of ADHD subtype inattention or impulse / hyperactivity as&#xD;
             established by a neuropsychologist.&#xD;
&#xD;
          -  Children will be between 8 and 18 years old&#xD;
&#xD;
          -  Adults will be between 18 and 75 years old.&#xD;
&#xD;
          -  Participants will not report any comorbid learning disabilities to ADHD.&#xD;
&#xD;
        For minors:&#xD;
&#xD;
        - Having obtained the written consent of the legal representative(s)&#xD;
&#xD;
        Healthy subjects&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
        - no known neurological injury&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laure PISELLA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de recherche de Neurosciences de Lyon (CRNL)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laure PISELLA, PhD</last_name>
    <phone>4 72 91 34 05</phone>
    <phone_ext>+33</phone_ext>
    <email>laure.pisella@inserm.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie OUERFELLI-ETHIER</last_name>
    <email>julie.ouerfelli-ethier@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre de Recherche en Neuroscience de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>laure PISELLA, PhD</last_name>
      <phone>4 72 91 34 05</phone>
      <phone_ext>+33</phone_ext>
      <email>laure.pisella@inserm.fr</email>
    </contact>
    <contact_backup>
      <last_name>Julie OUERFELLI-ETHIER</last_name>
      <email>julie.ouerfelli-ethier@inserm.fr</email>
    </contact_backup>
    <investigator>
      <last_name>laure PISELLA, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 11, 2020</study_first_submitted>
  <study_first_submitted_qc>February 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 21, 2020</study_first_posted>
  <last_update_submitted>April 7, 2020</last_update_submitted>
  <last_update_submitted_qc>April 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>attention-deficit hyperactivity disorder (ADHD)</keyword>
  <keyword>Attention Deficit Disorder with Hyperactivity</keyword>
  <keyword>attention</keyword>
  <keyword>inhibition</keyword>
  <keyword>Healthy Volunteers</keyword>
  <keyword>Perceptual Disorders</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

